94 related articles for article (PubMed ID: 1646730)
1. Comparison of several new 5-lipoxygenase inhibitors in a rat Arthus pleurisy model.
Berkenkopf JW; Weichman BM
Eur J Pharmacol; 1991 Jan; 193(1):29-34. PubMed ID: 1646730
[TBL] [Abstract][Full Text] [Related]
2. WY-50,295 tromethamine, a novel, orally active 5-lipoxygenase inhibitor: biochemical characterization and antiallergic activity.
Grimes D; Sturm RJ; Marinari LR; Carlson RP; Berkenkopf JW; Musser JH; Kreft AF; Weichman BM
Eur J Pharmacol; 1993 May; 236(2):217-28. PubMed ID: 8391458
[TBL] [Abstract][Full Text] [Related]
3. Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase.
McMillan RM; Spruce KE; Crawley GC; Walker ER; Foster SJ
Br J Pharmacol; 1992 Dec; 107(4):1042-7. PubMed ID: 1334748
[TBL] [Abstract][Full Text] [Related]
4. Leukotriene B4 production and pharmacologic regulation of reverse passive Arthus pleurisy: importance of antigen dose.
Weichman BM; Berkenkopf JW; Cullinan CA; Sturm RJ
Agents Actions; 1987 Aug; 21(3-4):351-4. PubMed ID: 2825482
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of leukotriene B4 biosynthesis by disulfiram and A-64077 during carrageenan-induced pleurisy in the rat.
Riendeau D; Guay J; Foster A; Wolfe S; Chan CC
Gen Pharmacol; 1991; 22(2):371-4. PubMed ID: 1647348
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of anti-inflammatory drugs on fluid accumulation and cellular infiltration in reverse passive arthus pleurisy and carrageenan pleurisy in rats.
Berkenkopf JW; Weichman BM
Pharmacology; 1987; 34(6):309-25. PubMed ID: 2958887
[TBL] [Abstract][Full Text] [Related]
7. Release of eicosanoids in rat peritoneal cavity during the Arthus reaction. Effect of the PAF-antagonist BN-52021 and indomethacin.
Jancar S; Braquet P; Sirois P
Int J Immunopharmacol; 1989; 11(2):129-32. PubMed ID: 2539337
[TBL] [Abstract][Full Text] [Related]
8. Role of leukotrienes in rat reversed passive Arthus pleurisy and the effect of AA-861, a 5-lipoxygenase inhibitor.
Makino H; Ashida Y; Saijo T; Kuriki H; Terao S; Maki Y
Int Arch Allergy Appl Immunol; 1986; 79(1):38-44. PubMed ID: 3000949
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of LTB4 biosynthesis in situ by CGS 23885, a potent 5-lipoxygenase inhibitor, correlates with its pleural fluid concentrations in an experimentally induced rat pleurisy model.
Raychaudhuri A; Chertock H; Chovan J; Jones LS; Kimble EF; Kowalski TJ; Peppard J; White DH; Satoh Y; Roland D
Naunyn Schmiedebergs Arch Pharmacol; 1997 Apr; 355(4):470-4. PubMed ID: 9109363
[TBL] [Abstract][Full Text] [Related]
10. Involvement of leukotriene B4 in zymosan-induced rat pleurisy: inhibition of leukocyte infiltration by the 5-lipoxygenase inhibitor T-0757.
Kikuchi M; Tsuzurahara K; Naito K
Biol Pharm Bull; 1995 Sep; 18(9):1302-4. PubMed ID: 8845830
[TBL] [Abstract][Full Text] [Related]
11. Role of corticosterone in modulation of eicosanoid biosynthesis and antiinflammatory activity by 5-lipoxygenase (5-LO) and cyclooxygenase (CO) inhibitors.
Tomchek LA; Hartman DA; Lewin AC; Calhoun W; Chau TT; Carlson RP
Agents Actions; 1991 Sep; 34(1-2):20-4. PubMed ID: 1665293
[TBL] [Abstract][Full Text] [Related]
12. Effects of TZI-41127, a novel selective 5-lipoxygenase inhibitor, on A23187-induced pleurisy in rats.
Hagiwara M; Mikami T; Iwamura S; Miyazawa K; Kobayashi M; Miyasaka K
Eur J Pharmacol; 1991 Jun; 199(1):69-75. PubMed ID: 1909963
[TBL] [Abstract][Full Text] [Related]
13. PAF modulates eicosanoids and TNF release in immune-complex arthritis in rats.
Rocha FA; Andrade LE; Russo M; Jancar S
J Lipid Mediat Cell Signal; 1997 May; 16(1):1-10. PubMed ID: 9101418
[TBL] [Abstract][Full Text] [Related]
14. Phospholipase A2 acyl-hydrolytic activity in rat RPAR-induced pleurisy.
Berkenkopf JW; Marinari LR; Weichman BM
Agents Actions; 1991 Sep; 34(1-2):93-6. PubMed ID: 1838900
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of methyl 7-butyl-4,5,6,7-tetrahydro-3-methylamino-4,6-dioxo-5-propyl-2H-pyrazol o[3, 4-d]pyrimidine-2-carboxylate (AA-2379) on type III allergic (Arthus) reaction.
Makino H; Naka T; Saijo T; Maki Y
Agents Actions; 1988 Dec; 25(3-4):326-35. PubMed ID: 2975457
[TBL] [Abstract][Full Text] [Related]
16. Actions of a 5-lipoxygenase inhibitor, Sch 40120, on acute inflammatory responses.
Smith SR; Watnick AW; Bryant RW; Billah M; Siegel MI
J Pharmacol Exp Ther; 1992 Aug; 262(2):721-8. PubMed ID: 1386887
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of 5-lipoxygenase inhibitors, zileuton, A-78773 and ICI-D-2138 in an ionophore (A-23187)-induced pleural inflammation model in the rat.
Rao TS; Currie JL; Shaffer AF; Isakson PC
Life Sci; 1993; 53(9):PL147-52. PubMed ID: 8394967
[TBL] [Abstract][Full Text] [Related]
18. Involvement of leukotrienes in allergic pleurisy in actively sensitized rats: inhibition by the lipoxygenase inhibitor T-0757 of the increase in vascular permeability and leukotriene E4 production.
Kikuchi M; Tsuzurahara K; Suzuki T; Yato N; Naito K
Inflamm Res; 1996 Apr; 45(4):192-7. PubMed ID: 8741009
[TBL] [Abstract][Full Text] [Related]
19. 5-lipoxygenase inhibitory activity of zileuton.
Carter GW; Young PR; Albert DH; Bouska J; Dyer R; Bell RL; Summers JB; Brooks DW
J Pharmacol Exp Ther; 1991 Mar; 256(3):929-37. PubMed ID: 1848634
[TBL] [Abstract][Full Text] [Related]
20. The effects of (R)-N-(1-methyl-2-phenylethyl) adenosine (L-PIA), a standard A1-selective adenosine agonist on rat acute models of inflammation and neutrophil function.
Lesch ME; Ferin MA; Wright CD; Schrier DJ
Agents Actions; 1991 Sep; 34(1-2):25-7. PubMed ID: 1838897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
